2024 ISPE Pharma 4.0™ and Annex 1 Conference

Hear From Top Industry Thought Leaders on the Challenges and Solutions Impacting the Pharmaceutical Industry

Why attend?

Case Studies

Expert Insights

Hear from industry leaders and regulators who will share their perspectives on the future of pharmaceuticals.

Technical Presentation

Pharma 4.0 Case Studies & Lessons Learned

Deep dive into case studies of digital business transformation to understand the benefits, challenges, and lessons learned from implementing digital solutions.

Technical Presentation

Annex 1 Implementation & Pharma 4.0

Learn strategies for implementing the latest Annex 1 version through real-world case studies, ensuring smooth operational changes and hardware integration. 

Construction

Pharma 4.0 Interconnected Facility Design & Construction

Gain insight into how 'plug and produce' principles offer opportunities for creating an integrated and interconnected facility, but also come with their challenges.

Case Studies

How ATMPs Manufacturing can be Supported by Annex 1 & Digital Transformation

Discover how the pharmaceutical industry can ensure the delivery of safe products to patients by improving their processes, implementing Annex 1, and utilizing enhanced data management for faster product release.

2024 ISPE Pharma 4.0™ and Annex 1 Conference

The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on digital transformation, automation, and the evolving landscape and future of Pharma 4.0™ supported Aseptic Manufacturing.

The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical chain. These sessions and workshops will showcase recent innovations and trends, and directly discuss practical challenges and solutions, from a technical, logistical, and regulatory perspective. The impact of Quality Risk Management (QRM) and Contamination Control Strategy (CCS) regulations, in particular for Annex 1, will be integrated throughout the conference programme and discussions. Participants will have the opportunity to engage with industry leaders, regulators, and peers through networking events and the conference programme.

Featured Speakers

Senior Advisor Biopharmaceuticals, Boehringer Ingelheim
Boehringer Ingelheim Pharma GmbH & Co KG
Head of Institute Surveillance
Austrian Agency for Health and Food Safety (AGES)

Your Conference Experience

2025 ISPE Biotechnology Conference
Expo Hall
Expo Hall
Explore groundbreaking innovations and network with industry leaders at our dynamic expo hall.
session-training
Professional Training
Professional Training
Connect with top industry experts and expand your professional network at our exclusive networking sessions.
2025 ISPE Europe Annual Conference
Live Streams
Live Streams
Experience the conference from anywhere with our interactive live stream.
2024 ISPE Pharma 4.0™ and Annex 1 Conference
Keynote Speakers
Keynote Speakers
Subject matter experts and top leaders in the pharmaceutical industry.
Conference Highlights

Pharma 4.0™ and Annex 1 – The Perfect Fit

SKAN AG and picture AI Generated through Hellen Denk

What do the EU GMP Annex 1 and the ISPE Baseline Guide Volume 8: Pharma 4.0™ (First Edition) have to do with each other?

ISPE Pharma 4.0™ and Annex 1 Conference Gallery

Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2024 ISPE Pharma 4.0™ and Annex 1 Conference.

Name
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

International Program Committee

Annex 1 Co-Chair
Senior Consultant Aseptic Processing & Containment
SKAN AG
Past Chair
Vice President Vetter Development Service External Affairs
Vetter Pharma Fertigung GmbH & Co KG
International Board Liaison
Senior Director, Global Engineering & Technology
Johnson & Johnson
Women in Pharma Liaison and Affiliate Liaison
Vice President Strategic Development, Marketing & Communication - Partner
PQE Group
Senior Industry Advisor and Principal Consultant for Advanced Therapies
Körber Pharma Software Inc
Emerging Leader
Network Technology Robotics Lead
F Hoffmann-La Roche AG